fda semaglutide compounding enforcement october 2025 GLP-1 Medications – Guidance and Compounded Products altRx GLP-1 Review 2026: Updated

Mahyar Etminan reported in the medical journal, JAMA , that GLP-1 receptor agonists like semaglutide (Ozempic), or liraglutide (Victoza) cause significantly more adverse events than do other classes of weight loss drugs like bupropion-naltrexone (Contrave)

However, because Gallups method of collecting self-reported weight and height has been consistent, the trend still provides valuable information regarding changes over time

GLP-1 treatments help counter these effects

If you experience severe pain, significant swelling, or signs of infection such as warmth, redness spreading beyond the injection site, or fever, contact a healthcare provider